Library Home | Reset filters
Select one or more filter options and click search below.
Reset filters
AUTHOR(S) Long Zhang; Marika Waselewski; Jack Nawrocki (et al.)
Adolescence is a critical time for adopting health behaviors which continue through adulthood. There is a lack of data regarding perspectives of US adolescents and young adults on their dental health and oral hygiene practice. Adolescents and young adults, age 14–24, from MyVoice, a nationwide text message poll of youth. were asked five open-ended questions on the importance of dental health and impact of the COVID-19 pandemic. Responses were qualitatively analyzed using thematic analysis. Chi-square test was used to examine differences in experiences by demographics.
AUTHOR(S) Zahra Rezaie; Vahid Kohpeima Jahromi; Vahid Rahmanian (et al.)
AUTHOR(S) Ida Henriette Caspersen; Lene K. Juvet; Berit Feiring (et al.)
A worldwide COVID-19 mass vaccination campaign targeting adults was launched in late December 2020. Subsequently, the Comirnaty (BNT162b2) vaccine was recommended for children aged 12–15 years in May 2021. In Norway, only one dose of the Comirnaty vaccine was recommended to children aged 12–15 years. Vaccination was not recommended for children who had been infected with SARS-CoV-2. In line with findings in older age groups, the most prevalent adverse events after vaccination that have been reported in 12- to 15-year-old adolescents are injection site pain (in 79 to 86 % of participants), fatigue (in 60 to 66 %), and headache (in 55 to 65 %). Adolescents aged 12–17 years have been found to have a moderately higher risk of adverse reactions than adults. For new vaccines, clinical trials typically collect data on commonly recognized adverse events and safety profiles. However, questions about the menstrual cycle have not been included in clinical studies. A significant number of reports on menstrual disturbances after COVID-19 vaccination have been registered in spontaneous adverse events surveillance systems in several countries (USA, UK, Norway, the Netherlands).
AUTHOR(S) Svitlana Shchudlo; Iryna Mirchuk; Oksana Zelena (et al.)
AUTHOR(S) Bi Ze; Bin Chen; Xiaoshan Ji (et al.)
Coronavirus disease 2019 (COVID-19) has been a most important global issue since December 2019. Although for children, the clinical course of COVID-19 is milder, it may still cause a multi-system inflammatory syndrome and has rendered 22,000 deaths among children and young people. The objective of this review is to provide an up-to-date information about COVID-19 related mortality and relevant risk factors in children and young people. This study provides a narrative review of COVID-19 related mortality and relevant risk factors in children and young people. Electronic searches for studies were conducted using PubMed and Web of Science, with a date time up to April 22, 2022. 22, 2022. Only publications in English were included.
AUTHOR(S) Jason M. Nagata; Jiayue Yu; Erin E. Dooley (et al.)
AUTHOR(S) Luis E. Fernández-Álvarez; Alejandro Carriedo; María Sánchez-Zafra (et al.)
AUTHOR(S) Aurelia Salussolia; Jacopo Lenzi; Marco Montalti (et al.)
AUTHOR(S) Cassandra Pingali; Fan Zhang; Tammy A. Santibanez (et al.)
Although COVID-19–associated illness is generally mild in adolescents, they can experience severe health outcomes, including hospitalization and death.1 COVID-19 vaccinations are effective for preventing serious COVID-19–associated illness in adolescents.1 The Advisory Committee on Immunization Practices (ACIP) recommends persons aged 6 months or older receive COVID-19 vaccination.2 As of April 14, 2022, among US individuals aged 12 to 17 years, COVID-19 vaccination coverage (≥1 dose) was 68%,3 lower than for other vaccines routinely recommended for adolescents.4 The ACIP recommends adolescents aged 11 to 12 years receive tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal conjugate (MenACWY), and human papillomavirus (HPV) vaccinations.2 This cross-sectional study investigated associations between routine adolescent vaccination status and parental intent or hesitancy to get a COVID-19 vaccine for their adolescent. The National Immunization Survey–Child COVID Module (NIS-CCM) is a national telephone survey of households with children or adolescents aged 6 months to 17 years used to measure parent-reported COVID-19 vaccination coverage and intent to vaccinate their child.5 The NIS-CCM uses the NIS-Child sampling frame; for adolescents aged 13 to 17 years, it follows the NIS-Teen interview, allowing for analysis of both routine (HPV, MenACWY, and Tdap) and COVID-19 vaccination coverage.5 NIS-CCM interviews from July 22, 2021, through February 26, 2022, were analyzed. Survey respondents were those self-reporting being most knowledgeable about the child’s vaccinations (hereafter, parent). Vaccination status was based on parental report. Data were weighted to represent the noninstitutionalized population of US adolescents and calibrated to administered vaccinations data.3 Analyses were performed using SAS, version 9.4
AUTHOR(S) Yanhui Dong; Catherine Jan; Li Chen (et al.)
This paper aimed to estimate the effects of school closures and associated lifestyle changes on myopia in Chinese children and adolescents during the coronavirus disease 2019 (COVID-19) pandemic. Two cross-sectional surveys recruited 14,296 Chinese students aged 7 to 18 years in November 2019 and June 2020 from which an open cohort study (nested queue design) was derived and used to assess myopia prevalence, incidence, and progression rates (defined as students with progression in myopia severity at the second survey wave among those with myopia at baseline). The severity of myopia was determined by measurements of visual acuity (<5.0) and noncycloplegic refraction (spherical equivalent <−0.50 diopters). Twenty-three myopia-influencing factors were divided into three categories: eye-use habits, lifestyle, and family and subjective factors. Responses to each of these 23 factors were labeled as either positive or negative options and then combined to generate a comprehensive score.
AUTHOR(S) Steward Mudenda; Moses Mukosha; Brian Godman (et al.)
AUTHOR(S) Jonathan K. Noel; Samantha R. Rosenthal; Samantha K. Borden (et al.)
AUTHOR(S) Kasahun Girma Tareke; Genzebie Tesfaye; Zewdie Birhanu Koricha
The study aimed in developing and validating a Health Belief Model (HBM) based instrument used for cross-sectional studies among secondary school students in Jimma town, Oromia, Ethiopia. A school-based cross-sectional study was conducted from May 25 to June 10, 2021. The sample size was 634, and students were randomly selected from public and private secondary schools. The 81 items were developed reviewing different literatures based on the constructs of HBM. The constructs were perceived severity, perceived vulnerability, perceived benefit, perceived barrier, self-efficacy, cues to action, perceived school support and self-protective practice. Data were collected using a self-administered questionnaire. The data were cleaned, entered into and analyzed using SPSS 23.0. A principal axis factoring with varimax rotation was carried out to extract items. Items with no loading factor or cross-loaded items were deleted. Items having factor loading coefficient of ≥0.4 were retained. An internal reliability was ensured at Cronbach’s alpha >0.70. All items with corrected item-total correlation coefficient below 0.30 were deleted from reliability analysis.
AUTHOR(S) Amos Omamo; Sarah Wandili; Stephen Mutua (et al.)
AUTHOR(S) Courtney A. Gidengil; Andrew M. Parker; Amber M. Gedlinske (et al.)
UNICEF Innocenti's Children and COVID-19 Library is a database collecting research from around the world on COVID-19 and its impacts on children and adolescents.
Subscribe to updates on new research about COVID-19 & children
Check our quarterly thematic digests on children and COVID-19
COVID-19 & Children: Rapid Research Response